about
Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regenerationUpdate on Guillain-Barré syndromeA processive lipid glycosyltransferase in the small human pathogen Mycoplasma pneumoniae: involvement in host immune responseComparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in BangladeshPrevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study.Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implicationsDevelopment of a novel therapy for Lipo-oligosaccharide-induced experimental neuritis: use of peptide glycomimicsNovel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.New insights into the pathogenesis and detection of Mycoplasma pneumoniae infectionsThe Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids.Human-derived natural antibodies: biomarkers and potential therapeuticsAntibodies to heteromeric glycolipid complexes in Guillain-Barré syndrome.Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.Rhamnose biosynthesis in mycoplasmas requires precursor glycans larger than monosaccharideAntiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: treatment update.O-linked protein glycosylation in Mycoplasma.Campylobacter bacteremia: a rare and under-reported event?Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain-Barré syndrome?Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.Clinical characteristics of Guillain-Barré syndrome in a tropical country: a Brazilian experience.Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease.Advances in Infectious Encephalitis: Etiologies, Outcomes, and Potential Links with Anti-NMDAR Encephalitis.Novel pathomechanisms in inflammatory neuropathies.T cell response in acute motor axonal neuropathy.Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome.Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies
P2860
Q26995291-B65D4092-37E9-4263-9019-1AA67ABA7F61Q28293098-BDA19AFA-DB82-4A90-B790-EAB333F51599Q28484726-B56DD653-13B3-40D6-86D5-7BA2EA1836B7Q33507527-0D01C807-7C98-424A-8309-55DD991350F0Q33594796-BF4F41CC-5524-404A-945A-7D483D641FCAQ34023899-96406786-C4A4-4FD2-A160-1461A512614DQ34451647-3353B0D8-2D20-4473-ACC8-296FB061C73EQ34451654-69FF6B18-FDD8-48E9-9CA4-632F1993D71FQ34619162-9784CFEF-B8A5-4969-AC18-BD05F39C8C20Q34657784-FEFFFBA5-E9C9-4550-AC05-7A730E653295Q34677183-D7B275C5-BA83-4DB2-B0A1-4381A94E550FQ35064053-B1E386B0-9FCA-4A28-88DC-5EB155D266C3Q35072720-C20076E8-E63B-4453-BE26-ABB878BAA532Q36174702-27DC7ABE-25C7-4035-B015-6F711A4B0EB0Q37016196-66E5C80A-F4A5-4975-ACD7-FDD8F99B2784Q37166458-5CC0C6E9-5662-4DC8-A582-EE2BCE2FCEBBQ37207391-1956F278-D9F5-4ED7-BD64-E5CCCA1C7DACQ37329516-DBF41359-ED38-42FB-A0B1-7B7A36D901D5Q37350902-D77812C1-168B-4BB1-A0F6-74FF1D9B5763Q37601783-9F8A7597-7796-4837-8983-312C1FAE7D1FQ37782118-622DF9A9-C941-4042-B35A-AB1370263F6FQ37921765-D8ED4A48-578C-4AB2-9261-54F1A2382097Q38977289-60974240-1D09-4A87-A764-F7381015579CQ39167266-737AF1C8-F384-45D2-BACD-7CB360D38F0CQ42242851-3094D04C-CCDE-487F-BDA7-EFCF8BF77A72Q47126672-55353AF5-37B8-4A66-A7C9-C5F4A7BA9E83Q48345339-7D8EB396-B088-4EF0-B502-85243BBCFC70Q51612785-EE75FB92-A361-4FBE-A6E5-4F1D3D14E0A9Q52422645-9B215CF0-CA35-4347-8C7D-A6CF99C61F54Q57300562-948B751D-34A1-4DEF-8A53-B375B8005094
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Ganglioside mimicry and peripheral nerve disease.
@ast
Ganglioside mimicry and peripheral nerve disease.
@en
type
label
Ganglioside mimicry and peripheral nerve disease.
@ast
Ganglioside mimicry and peripheral nerve disease.
@en
prefLabel
Ganglioside mimicry and peripheral nerve disease.
@ast
Ganglioside mimicry and peripheral nerve disease.
@en
P2860
P356
P1433
P1476
Ganglioside mimicry and peripheral nerve disease.
@en
P2093
Nobuhiro Yuki
P2860
P304
P356
10.1002/MUS.20762
P577
2007-06-01T00:00:00Z